Rare cancer cell analyzer for whole blood applications: Microcytometer cell counting and sorting subcircuits

被引:29
作者
Lancaster, C [1 ]
Kokoris, A [1 ]
Nabavi, M [1 ]
Clemmens, J [1 ]
Maloney, P [1 ]
Capadanno, J [1 ]
Gerdes, J [1 ]
Battrell, CF [1 ]
机构
[1] Micronics Inc, Redmond, WA 98052 USA
关键词
rare cells; cell sorting; cell counting; microcytometer; microfluidic;
D O I
10.1016/j.ymeth.2005.07.003
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We demonstrate sorting of rare cancer cells from blood using a thin ribbon monolayer of cells within a credit-card sized, microfluidic laboratory-on-a-card ("lab card") structure. This enables higher cell throughput per minute thereby speeding up cell interrogation. In this approach, multiple cells are viewed and sorted, not individually, but as a whole cell row or section of the ribbon at a time. Gated selection of only the cell rows containing a tagged rare cell provides enrichment of the rare cell relative to background blood cells. We also designed the cell injector for laminar flow antibody labeling within 20 s. The approach combines rapid laminar flow cell labeling with monolayer cell sorting thereby enabling rare cell target detection at sensitivity levels 1000 to 10,000 times that of existing flow cytometers. Using this method, total cell labeling and data acquisition time on card may be reduced to a few minutes compared to 30-60 min for standard flow methods. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:120 / 127
页数:8
相关论文
共 10 条
[1]  
BATTRELL F, 2002, MICRO TOTAL ANAL SYS
[2]   Mechanisms of disease - The biology of chronic myeloid leukemia [J].
Faderl, S ;
Talpaz, M ;
Estrov, Z ;
O'Brien, S ;
Kurzrock, R ;
Kantarjian, HM .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (03) :164-172
[3]   Molecular detection and characterization of circulating tumor cells and micrometastases in prostatic, urothelial, and renal cell carcinomas [J].
Ghossein, RA ;
Bhattacharya, S .
SEMINARS IN SURGICAL ONCOLOGY, 2001, 20 (04) :304-311
[4]   Assessing agreement between CD34 enumeration by flow cytometry and volumetric analysis [J].
Gisselo, CG ;
Roer, O ;
Hoffmann, MH ;
Hansen, MB ;
Taaning, E ;
Johnsen, HE .
BONE MARROW TRANSPLANTATION, 2002, 29 (08) :699-703
[5]  
Gratama JW, 1998, CYTOMETRY, V34, P128, DOI 10.1002/(SICI)1097-0320(19980615)34:3<128::AID-CYTO3>3.0.CO
[6]  
2-D
[7]   Cytogenetic and molecular genetic evolution of chronic myeloid leukemia [J].
Johansson, B ;
Fioretos, T ;
Mitelman, F .
ACTA HAEMATOLOGICA, 2002, 107 (02) :76-94
[8]   Chronic myelogenous leukaemia - new therapeutic principles [J].
O'Dwyer, ME ;
Druker, BJ .
JOURNAL OF INTERNAL MEDICINE, 2001, 250 (01) :3-9
[9]   Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia [J].
Olavarria, E ;
Kanfer, E ;
Szydlo, R ;
Kaeda, J ;
Rezvani, K ;
Cwynarski, K ;
Pocock, C ;
Dazzi, F ;
Craddock, C ;
Apperley, JF ;
Cross, NCP ;
Goldman, JM .
BLOOD, 2001, 97 (06) :1560-1565
[10]  
Román J, 2000, HAEMATOLOGICA, V85, P1072